RAPID MICRO BIOSYSTEMS, INC. 8-K

What Happened
Rapid Micro Biosystems, Inc. (RPID) filed a Form 8-K on January 13, 2026 (Item 2.02) disclosing that it issued a press release announcing preliminary, unaudited revenue results and certain business highlights for the fourth quarter and full year ended December 31, 2025. The press release is attached to the 8-K as Exhibit 99.1 and is incorporated by reference. The report was signed by CFO Sean Wirtjes.

Key Details

• Filing date: January 13, 2026 (Form 8-K, Item 2.02).
• Scope of results: Preliminary, unaudited revenue results and business highlights for Q4 and full year ended December 31, 2025.
• Exhibits: Press release attached as Exhibit 99.1; interactive XBRL cover page included as Exhibit 104.
• Authorized signature: Report signed by Sean Wirtjes, Chief Financial Officer.

Why It Matters
This 8-K is the company’s first public disclosure of preliminary revenue for Q4 and FY2025, which can provide an early look at recent earnings and revenue trends. Because the numbers are described as preliminary and unaudited, they may be updated in subsequent filings (e.g., quarterly or annual reports). Investors should review the attached press release for the specific figures and monitor upcoming audited filings for full financial details and context.